A documentary on the future of scientific research beyond animal testing was recently released by Quirks & Quarks. Charu Chandrasekera, a former biomedical researcher, shifted her focus to developing alternatives to animal testing after realizing the limitations of animal studies in translating to human benefits. Despite advancements like 3D bioprinting of human cell tissues for research, funding challenges led to the closure of her lab in 2024.
While other countries have dedicated funding and roadmaps to phase out animal testing, Canada lacks a comprehensive strategy for replacing animals in biomedical research, which constitutes a significant portion of the up to five million animals used annually in Canadian research facilities. Chandrasekera emphasizes the growing industry of alternatives to animal testing, projected to reach $30 billion by 2030, urging Canada to seize this opportunity.
Innovations like organ-on-a-chip technology, developed by researchers such as Milica Radisic, offer promising alternatives to animal testing. These advancements aim to provide more accurate and ethical approaches to biomedical research. However, the acceptance of alternative methods by regulators, particularly Health Canada, remains a crucial step in transitioning away from animal testing.
While some researchers acknowledge the value of animal models in scientific research, there is a growing push towards adopting alternative technologies to ensure the safety and efficacy of products. The role of regulators, like the Canadian Council on Animal Care, in evaluating and approving alternative methods is essential for the future of research practices.
Funding plays a vital role in driving the transition towards alternatives to animal testing. While countries like the U.S. and the U.K. have made significant investments in this area, Canada is yet to propose funding for such initiatives. Without adequate support, researchers like Chandrasekera fear being compelled to seek resources outside of Canada, highlighting the importance of national leadership and collaboration in advancing ethical research practices.